145 related articles for article (PubMed ID: 9400013)
1. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.
Williams DP; Pirmohamed M; Naisbitt DJ; Maggs JL; Park BK
J Pharmacol Exp Ther; 1997 Dec; 283(3):1375-82. PubMed ID: 9400013
[TBL] [Abstract][Full Text] [Related]
2. Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis.
Pereira A; Dean B
Biochem Pharmacol; 2006 Sep; 72(6):783-93. PubMed ID: 16844094
[TBL] [Abstract][Full Text] [Related]
3. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.
Maggs JL; Williams D; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1463-75. PubMed ID: 8531117
[TBL] [Abstract][Full Text] [Related]
4. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
Fischer V; Haar JA; Greiner L; Lloyd RV; Mason RP
Mol Pharmacol; 1991 Nov; 40(5):846-53. PubMed ID: 1658615
[TBL] [Abstract][Full Text] [Related]
5. Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine.
Dragovic S; Boerma JS; van Bergen L; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2010 Sep; 23(9):1467-76. PubMed ID: 20849150
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis.
Tschen AC; Rieder MJ; Oyewumi LK; Freeman DJ
Clin Pharmacol Ther; 1999 May; 65(5):526-32. PubMed ID: 10340918
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes.
Gardner I; Zahid N; MacCrimmon D; Uetrecht JP
Mol Pharmacol; 1998 Jun; 53(6):991-8. PubMed ID: 9614200
[TBL] [Abstract][Full Text] [Related]
8. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
Li X; Cameron MD
Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and bioactivation of clozapine by human liver in vitro.
Pirmohamed M; Williams D; Madden S; Templeton E; Park BK
J Pharmacol Exp Ther; 1995 Mar; 272(3):984-90. PubMed ID: 7891353
[TBL] [Abstract][Full Text] [Related]
10. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells.
Liu ZC; Uetrecht JP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1476-83. PubMed ID: 8531118
[TBL] [Abstract][Full Text] [Related]
11. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
Williams DP; Pirmohamed M; Naisbitt DJ; Uetrecht JP; Park BK
Mol Pharmacol; 2000 Jul; 58(1):207-16. PubMed ID: 10860943
[TBL] [Abstract][Full Text] [Related]
12. Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs.
Naisbitt DJ; Williams DP; O'Neill PM; Maggs JL; Willock DJ; Pirmohamed M; Park BK
Chem Res Toxicol; 1998 Dec; 11(12):1586-95. PubMed ID: 9860505
[TBL] [Abstract][Full Text] [Related]
13. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
Iverson S; Zahid N; Uetrecht JP
Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
[TBL] [Abstract][Full Text] [Related]
14. Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: implications for fluperlapine-induced agranulocytosis.
Lai WG; Gardner I; Zahid N; Uetrecht JP
Drug Metab Dispos; 2000 Mar; 28(3):255-63. PubMed ID: 10681368
[TBL] [Abstract][Full Text] [Related]
15. Effect of clozapine on neutrophil kinetics in rabbits.
Iverson S; Kautiainen A; Ip J; Uetrecht JP
Chem Res Toxicol; 2010 Jul; 23(7):1184-91. PubMed ID: 20553052
[TBL] [Abstract][Full Text] [Related]
16. A Reactive Metabolite of Clozapine Induces Hematopoietic Toxicity in HL-60 Cells Undergoing Granulocytic Differentiation through Its Effect on Glutathione Metabolism.
Torii-Goto A; Yoshimi A; Tashiro Y; Ukigai M; Matsumoto A; Ozaki N; Noda Y
Biol Pharm Bull; 2022; 45(9):1232-1237. PubMed ID: 36047190
[TBL] [Abstract][Full Text] [Related]
17. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
18. Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro.
Williams DP; O'Donnell CJ; Maggs JL; Leeder JS; Uetrecht J; Pirmohamed M; Park BK
Chem Res Toxicol; 2003 Oct; 16(10):1359-64. PubMed ID: 14565776
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis.
Pisciotta AV; Konings SA; Ciesemier LL; Cronkite CE; Lieberman JA
J Lab Clin Med; 1992 Mar; 119(3):254-66. PubMed ID: 1541875
[TBL] [Abstract][Full Text] [Related]
20. Structural features associated with reactive metabolite formation in clozapine analogues.
Uetrecht J; Zahid N; Tehim A; Fu JM; Rakhit S
Chem Biol Interact; 1997 May; 104(2-3):117-29. PubMed ID: 9212779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
